PULMONX CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 26.58K shares, a 48.78% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 71.84K shares, a 28.92% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 2.90K shares, a 77.03% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 145.44K shares, a 34.89% increase from fiscal 2024.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 107.82K shares, a 21.82% decline from fiscal 2023.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 137.90K shares, a 53.64% decline from fiscal 2022.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 297.46K shares, a 72.08% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 101.33K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 26.58K shares 10-Q · filed 2026-05-04 | 120.12K shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 71.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 145.44K shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 2.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 129.32K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-06-30 | 18.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | 139.04K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-03-31 | 51.90K shares 10-Q · filed 2025-05-02 | 131.60K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | 55.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 107.82K shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 12.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 78.30K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-06-30 | 11.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 90.86K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | 28.12K shares 10-Q · filed 2024-05-03 | 143.01K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | 26.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 137.90K shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 25.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 206.33K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | 63.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 211.09K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | 23.01K shares 10-Q · filed 2023-05-08 | 221.20K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | 94.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 297.46K shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 29.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 294.11K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | 73.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 461.99K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | 99.27K shares 10-Q · filed 2022-05-09 | 1.04M shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | 91.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 1.07M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 197.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 1.01M shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | 653.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | |
| 2021-03-31 | 122.86K shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 33.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.75M shares 10-K · filed 2022-03-01 |
| 2019-12-31 | 390.32K shares 10-K · filed 2021-03-15 | |
| 2018-12-31 | 18.15K shares 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |